Skip to main content
. 2021 Nov 27;48(2):402–410. doi: 10.1111/jog.15108

TABLE 1.

Demographic and characteristics of COVID‐19 patient

Variables Severe patients (n = 12) Non‐severe patients (n = 98) All patients (n = 110) p‐Value
Age, median (min.–max.), years 31 (21–36) 30 (19–42) 30 (19–42) 0.758 a
Gestational age, median (min.–max.), weeks 35 (22–38) 37 (28–41) 37 (22–41) 0.005 a
Maternal country of birth
Turkey 10 (83.3%) 92 (93.9%) 102 (92.7%) 0.21 b
Syria 2 (16.7%) 6 (5.1%) 8 (7.3%)
Coexisting disorders
Pneumonia 12 (100%) 45 (45.6%) 57 (51.8%) 0.003 c
Preeclampsia/hypertensive disease 3 (25%) 8 (8.2%) 11 (10%) 0.09 c
Diabetes (pregestational and gestational) 2 (16.7%) 7 (7.1%) 9 (8.1%) 0.25 c
Asthma 2 (16.7%) 3 (3.1%) 5 (4.5%) 0.091 c
ASA score
2 3 (25%) 79 (80.1%) 82 (74.5%) 0.001 c
3 4 (33.3) 16 (16.3%) 20 (18.2%) 0.22 c
4 5 (41.7%) 3 (3.1%) 8 (7.3%) <0.001 c
Emergency operation 8 (66.7%) 18 (18.4) 26 (23.6%) <0.001 c
Nulliparity 1 (8.3%) 17 (17.3%) 18 (16.4%) 0.68 c
Twin pregnancies 1 (8.3%) 3 (3.1%) 4 (3.6%) 0.37 c

Note: Significant values are in bold and italics.

Abbreviation: ASA, American Society of Anesthesiology.

a

Mann–Whitney U test.

b

Fisher exact test for two race groups.

c

Fisher exact test.